Development of albuminuria and enhancement of oxidative stress during chronic renin–angiotensin system suppression-Reference-Cited by-同舟云学术

Development of albuminuria and enhancement of oxidative stress during chronic renin–angiotensin system suppression

Published:2014-10 Issue:10 Volume:32 Page:2082-2091
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Ruiz-Hurtado Gema,Condezo-Hoyos Luis,Pulido-Olmo Helena,Aranguez Isabel,del Carmen Gónzalez Maria,Arribas Silvia,Cerezo César,Segura Julián,Praga Manuel,Fernández-Alfonso Maria S.,Ruilope Luis Miguel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference56 articles.

1. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men.;DellOmo;Am J Kidney Dis,2002

2. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.;Hillege;Circulation,2002

3. How should we manage heart failure developing in patients already treated with angiotensin-converting enzyme inhibitors and beta-blockers for hypertension, diabetes or coronary disease J H;Gustafsson;ypertens,2010

4. Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression.;Cerezo;J Hypertens,2012

5. Albuminuria reflects widespread vascular damage. The Steno hypothesis.;Deckert;Diabetologia,1989

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis;Antioxidants;2024-01-16

2. Serum vitamin C levels and their correlation with chronic kidney disease in adults: a nationwide study;Renal Failure;2024-01-08

3. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors;Biomedicine & Pharmacotherapy;2023-12

4. Therapeutic perspective: evolving evidence of nonsteroidal mineralocorticoid receptor antagonists in diabetic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2023-06-01

5. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease;International Journal of Molecular Sciences;2022-12-20